'FDA Won't Take Action Against GLP-1 Compounders As It Rethinks Tirzepatide Shortage' - Endpoints News

Benzinga · 10/18 19:10

https://endpts.com/glp-1-drugs-from-compounders-wont-be-targeted-by-fda-for-now/

The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates Eli Lilly's weight loss and diabetes drug …